Previous 10 | Next 10 |
Image source: The Motley Fool. Integra Lifesciences Holdings Corp (NASDAQ: IART) Q1 2021 Earnings Call Apr 28, 2021 , 8:30 a.m. ET Operator Continue reading For further details see: Integra Lifesciences Holdings Corp (IART) Q1 2021 Earnin...
Integra LifeSciences Holdings (IART): Q1 Non-GAAP EPS of $0.69 beats by $0.12; GAAP EPS of $0.53 beats by $0.29.Revenue of $360.07M (+1.6% Y/Y) beats by $10.29M.Press Release For further details see: Integra LifeSciences Holdings EPS beats by $0.12, beats on revenue
PRINCETON, N.J., April 28, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, today reported financial results for the first quarter ending March 31, 2021. First Quarter 2021 Financial Summary ...
Warning signals are flashing, suggesting it could be smart to fade the next move up. The strongest sectors currently include financials, REITs, and consumer goods. Over 100 highly-rated stocks across every major sector for your watch lists. For further details see: One L...
#Investors in Integra Lifesciences Hldg (NASDAQ: IART) like to make good #decisions, that means they like to #buyandsell at the right times, and to do that the best tools involve charts, pivot points, and the technical data. Below, we have provided a snapshot for IART...
PRINCETON, N.J., April 19, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company and manufacturer of SurgiMend Collagen Matrix, today issued the following statement regarding the U.S. FDA safety communication ...
This Integra Lifesciences Hldg (NASDAQ: IART) report helps investors and traders identify both opportunity, and potential red flags, by using the price action of the stock. The trading plans for IART have risk controls, and that make these observations both opportunistic and defen...
Integra is well-placed to benefit from post-pandemic normalization, as trauma cases will likely increase, driving more demand for neurosurgical tools and wound care products. Selling the extremities business and buying ACell is a good trade, boosting growth, margins, and capital effic...
PRINCETON, N.J., April 08, 2021 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, will release first quarter 2021 financial results on Wednesday, April 28, 2021 prior to market open. In conjunction with the earning...
No matter what industry we are talking about, political decisions, and policy changes can affect the price of the stocks in that industry, and Integra Lifesciences Hldg (NASDAQ: IART) is not an exception. IART like every other company, it will experience ebbs and flows based on th...
News, Short Squeeze, Breakout and More Instantly...
Integra LifeSciences Holdings Corporation Company Name:
IART Stock Symbol:
NASDAQ Market:
Integra LifeSciences Holdings Corporation Website:
2024-07-30 13:15:02 ET JMP Securities analyst issues MARKET OUTPERFORM recommendation for IART on July 30, 2024 11:36AM ET. The previous analyst recommendation was Market Outperform. IART was trading at $24.945 at issue of the analyst recommendation. The overall analyst ...
2024-07-30 10:00:08 ET Richard Newitter from Truist Financial issued a price target of $26.00 for IART on 2024-07-30 08:59:00. The adjusted price target was set to $26.00. At the time of the announcement, IART was trading at $24.59. The overall price target consensus is ...
2024-07-30 06:30:09 ET Citigroup analyst issues SELL recommendation for IART on July 30, 2024 03:24AM ET. The previous analyst recommendation was Neutral. IART was trading at $25.42 at issue of the analyst recommendation. The overall analyst consensus : SELL. Current...